Identification of 2-Amino Benzothiazoles with Bactericidal Activity against Mycobacterium tuberculosis

被引:1
|
作者
Bonnett, Shilah [1 ]
Jee, Jo-Ann [1 ]
Chettiar, Somsundaram [1 ]
Ovechkina, Yulia [1 ]
Korkegian, Aaron [1 ]
Greve, Eric [2 ]
Odingo, Joshua [1 ]
Parish, Tanya [1 ,2 ]
机构
[1] TB Discovery Res Infect Dis Res Inst, Seattle, WA 98102 USA
[2] Seattle Childrens Res Inst, Ctr Global Infect Dis Res, Seattle, WA 98105 USA
来源
MICROBIOLOGY SPECTRUM | 2023年 / 11卷 / 01期
基金
美国国家卫生研究院;
关键词
antitubercular; drug discovery; antibiotic; protein secretion; bactericidal activity; tuberculosis; DRUGS;
D O I
10.1128/spectrum.04974-22
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Mycobacterium tuberculosis, the causative agent of tuberculosis, is a serious global health problem requiring the development of new therapeutics. We previously ran a high-throughput screen and identified a series of compounds with antitubercular activity. We identified an amino-benzothiazole scaffold from a whole-cell screen against recombinant Mycobacterium tuberculosis under expressing the essential signal peptidase LepB. The seed molecule had 2-fold higher activity against the LepB hypomorph. Through a combination of purchase and chemical synthesis, we explored the structure-activity relationship for this series; 34 analogs were tested for antitubercular activity and for cytotoxicity against eukaryotic cells. We identified molecules with improved potency and reduced cytotoxicity. However, molecules did not appear to target LepB directly and did not inhibit protein secretion. Key compounds showed good permeability, low protein binding, and lack of CYP inhibition, but metabolic stability was poor with short half-lives. The seed molecule showed good bactericidal activity against both replicating and nonreplicating bacteria, as well as potency against intracellular M. tuberculosis in murine macrophages. Overall, the microbiological properties of the series are attractive if metabolic stability can be improved, and identification of the target could assist in the development of this series.IMPORTANCE Mycobacterium tuberculosis, the causative agent of tuberculosis, is a serious global health problem requiring the development of new therapeutics. We previously ran a high-throughput screen and identified a series of compounds with antitubercular activity. In this paper, we test analogs of our hit molecules for activity against M. tuberculosis, as well as for activity against eukaryotic cells. We identified molecules with improved selectivity. Our molecules killed both replicating and nonreplicating bacteria but did not work by targeting protein secretion.
引用
收藏
页数:17
相关论文
共 50 条
  • [31] BACTERICIDAL ACTIVITY OF ETHAMBUTOL AGAINST EXTRACELLULAR MYCOBACTERIUM-TUBERCULOSIS AND BACILLI PHAGOCYTIZED BY HUMAN ALVEOLAR MACROPHAGES
    LISS, RH
    SOUTH AFRICAN MEDICAL JOURNAL, 1982, : 15 - 19
  • [32] Early bactericidal activity of sitafloxacin against pulmonary tuberculosis
    Nie, Lihui
    Tong, Jing
    Wu, Guihui
    Du, Juan
    Shang, Yuanyuan
    Wang, Yufeng
    Wu, Zhangjun
    Xu, Yuanhong
    Ren, Yi
    Rao, Youyi
    Pang, Yu
    Gao, Mengqiu
    MICROBIOLOGY SPECTRUM, 2025, 13 (01)
  • [33] Bactericidal Activity of Moxifloxacin on Exponential and Stationary Phase Cultures of Mycobacterium tuberculosis
    Sulochana, S.
    Mitchison, D. A.
    Kubendiren, G.
    Venkatesan, P.
    Paramasivan, C. N.
    JOURNAL OF CHEMOTHERAPY, 2009, 21 (02) : 127 - 134
  • [34] Bactericidal activity of 2-nitroimidazole against the active replicating stage of Mycobacterium bovis BCG and Mycobacterium tuberculosis with intracellular efficacy in THP-1 macrophages
    Khan, Arshad
    Sarkar, Sampa
    Sarkar, Dhiman
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2008, 32 (01) : 40 - 45
  • [35] TLC SEPARATION OF SOME ISOMERIC 2 AND 6-[2-AMINO (SUBSTITUTED AMINO)-4-THIAZOLYL] BENZOTHIAZOLES
    SINGH, SP
    PRAKASH, O
    TOMAR, RK
    FRESENIUS ZEITSCHRIFT FUR ANALYTISCHE CHEMIE, 1977, 288 (04): : 285 - 285
  • [36] Bedaquiline Eliminates Bactericidal Activity of β-Lactams against Mycobacterium abscessus
    Lindman, Marissa
    Dick, Thomas
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2019, 63 (08)
  • [37] In vitro growth inhibition and bactericidal activity of spathulenol against drug-resistant clinical isolates of Mycobacterium tuberculosis
    de Jesus Dzul-Beh, Angel
    Garcia-Sosa, Karlina
    Humberto Uc-Cachon, Andres
    Borquez, Jorge
    Loyola, Luis A.
    Barrios-Garcia, Hugo B.
    Manuel Pena-Rodriguez, Luis
    Maria Molina-Salinas, Gloria
    REVISTA BRASILEIRA DE FARMACOGNOSIA-BRAZILIAN JOURNAL OF PHARMACOGNOSY, 2019, 29 (06): : 798 - 800
  • [38] In vitro growth inhibition and bactericidal activity of spathulenol against drug-resistant clinical isolates of Mycobacterium tuberculosis
    Angel Jesús de Dzul-Beh
    Karlina García-Sosa
    Andrés Humberto Uc-Cachón
    Jorge Bórquez
    Luis A. Loyola
    Hugo B. Barrios-García
    Luis Manuel Peña-Rodríguez
    Gloria María Molina-Salinas
    Revista Brasileira de Farmacognosia, 2019, 29 : 798 - 800
  • [39] In Vitro Activity of Tedizolid against Mycobacterium tuberculosis
    Ruiz, Pilar
    Causse, Manuel
    Vaquero, Manuel
    Casal, Manuel
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2019, 63 (04)
  • [40] Activity of Drugs Against Dormant Mycobacterium tuberculosis
    Piccaro, G.
    Filippini, P.
    Giannoni, F.
    Scipione, L.
    Tortorella, S.
    De Vita, D.
    Mellini, P.
    Fattorini, L.
    JOURNAL OF CHEMOTHERAPY, 2011, 23 (03) : 175 - 178